Sector 08
Biomedical & Medtech Manufacturing
Singapore's biomedical manufacturing runs on a regulatory licence, not a marketing claim. The Health Sciences Authority lists 206 Manufacturer licences in its Medical Device Dealer's Licence Database, each tied to a registered Singapore facility address and every device model registered against that site. Verified device manufacturers number 29; roughly 20-25% are SMEs, and 16 of the 29 are multinational subsidiaries. Multinationals — Medtronic, Edwards, BD, Baxter, Alcon — anchor the base, alongside a local layer building diagnostics and medical robotics. Manufacturing concentrates at Tuas Biomedical Park and across the western industrial belt.
Cleanroom assembly is a distinct, cross-cutting capability: four companies sell it as a named service line, and it is shared with the semiconductor hub. Biologics manufacturing is emerging — a PIC/S-GMP gene-therapy CDMO builds viral vectors at Pasir Panjang. Contract sterilisation is thin: Singapore has ethylene-oxide capacity at Jalan Buroh but no gamma or e-beam, so devices needing those methods ship to Malaysia and Thailand.
Buyers here are global procurement functions, not searchers, which is why a flagship cluster generates almost no measured search demand. The record, not the search box, is where this sector is found.
Capabilities
8 sub-sectors
- Biopharmaceutical manufacturing in Singapore Manufacture of biologic drug substance — monoclonal antibodies, recombinant and fusion proteins, and vaccines — grown in mammalian cell culture or microbial fermentation, purified and released as bulk. Buyers select on modality, expression system and bioreactor fleet, captive-versus-CDMO model, and FDA, EMA and HSA inspection record under PIC/S GMP.
- Cell and gene therapy manufacturing in Singapore GMP production of living therapeutics — autologous and allogeneic cell therapies, viral vectors and plasmid DNA. Buyers select on modality, platform and scale, stage from clinical-trial material to commercial supply, and captive-versus-shared-versus-CDMO contracting model under HSA's cell, tissue and gene therapy product regime.
- Cleanroom assembly services in Singapore Assembly of devices and components in controlled environments where airborne particle counts are regulated to ISO 14644 classes. Covers gowning, filtered air, and contamination control for implants, catheters, diagnostics, and optical and electronic parts. Buyers select on certified cleanroom class, particle-monitoring records, and quality system certification.
- Contract development and manufacturing (CDMO) in Singapore Contract process development and GMP production of medicines for pharma and biotech clients that lack their own plants or want to flex capacity. Buyers select on modality coverage, stage from preclinical and clinical material to commercial supply, capacity and technology, and FDA, EMA and HSA regulatory track record.
- Fill-finish and aseptic manufacturing in Singapore Aseptic transfer of a purified drug substance into its final sterile container — vial, prefilled syringe or cartridge — sealed, optionally lyophilised, inspected and released. Buyers select on container format, lyophilisation capacity, small-versus-large-molecule filling, isolator or RABS containment, and aseptic-process-simulation and PIC/S GMP record.
- Medical device manufacturing services in Singapore Contract production of medical devices and their components under a certified quality system. Work spans injection moulding, precision machining, assembly, and electronics integration for Class I to III devices. Buyers select suppliers on ISO 13485 certification, device-class and regulatory experience, cleanroom capacity, and traceable design and manufacturing records.
- Pharmaceutical manufacturing in Singapore Manufacture of small-molecule active pharmaceutical ingredients (APIs) by chemical synthesis and their formulation into oral solid dose and other finished forms. Buyers select on API-versus-finished-dose scope, containment and high-potency (HPAPI) capability, batch-versus-continuous technology, and PIC/S GMP licensing under the Health Sciences Authority.
- Sterile medical packaging services in Singapore Design and production of sterile barrier packaging that protects medical devices through sterilization and distribution. Formats include pouches, trays, and Tyvek-lidded systems produced by form-fill-seal and heat sealing. Buyers select on ISO 11607 validation, seal-integrity testing, and compatibility with ethylene oxide, gamma, or steam sterilization.
Reference records
Compiled from public sources — free for each to claim
- AbbVie Operations Singapore
- Actris (Advanced Cell Therapy and Research Institute, Singapore)
- Advanced Materials Technologies
- Alcon
- Amcor
- Amgen Singapore Manufacturing
- Baxter
- Beacons Pharmaceuticals
- Becton Dickinson (BD)
- Beyonics
- Biosensors International
- Edwards Lifesciences
- Esco Aster
- Flex (Singapore)
- Forefront Medical Technology
- GSK (Singapore)
- Hilleman Laboratories
- Hoya Surgical Optics
- ICM Pharma
- Inzign
- Jabil (Singapore)
- Lonza Biologics Tuas
- Medtronic
- Meiban Group
- MiRXES
- MSD (Merck & Co)
- Nelipak
- Novartis Singapore
- Oliver Healthcare Packaging
- Osteopore International
- PCI Limited
- Pfizer (Singapore)
- Racer Technology / Racer Medical
- Roche Singapore Technical Operations
- Sanofi (Evolutive Vaccine Facility)
- STERIS (STERIS Tomoe Singapore)
- Sunningdale Tech
- SUPERPAK
- Takeda Manufacturing Singapore
- Thermo Fisher Scientific (Patheon Pharma Services)
- WuXi Biologics (Singapore)
- WuXi XDC